Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01497158 · ClinicalTrials.gov registry record · NA

Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking Adults

A NA study of Smoking Cessation and Tobacco Use Disorder, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
122
Enrollment target
1
Study location

NCT01497158 is a NA study of Smoking Cessation and Tobacco Use Disorder that has completed, run by University of Minnesota. The registered enrollment target is 122 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01497158, a NA study of Smoking Cessation and Tobacco Use Disorder, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
1
Study location

Study Summary

This study is directed at decreasing home environmental tobacco smoking (ETS) exposure with a novel approach of adoption of home smoking restrictions. This will be done by providing the cohabitating smoker and non-smoker with biomarker feedback documenting exposure to ETS. The intent is to identify an intervention strategy(ies) to reduce ETS exposure.

Interventions

  • OTHER Self-help brochure
  • OTHER Biomarker feedback

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2007-06
Est. Completion 2012-02
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT01497158

The ClinicalTrials.gov registry entry for NCT01497158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (74% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Self-help brochure is the first listed.

NCT01497158 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01497158 about?

NCT01497158 is a clinical study titled "Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking Adults". This study is directed at decreasing home environmental tobacco smoking (ETS) exposure with a novel approach of adoption of home smoking restrictions. This will be done by providing the cohabitating smoker and non-smoker with biomarker feedback documenting exposure to ETS. The intent is to identify ...

What is the current status of trial NCT01497158?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2007-06. Estimated completion is 2012-02.

What conditions does trial NCT01497158 study?

This clinical trial studies the following conditions: Smoking Cessation, Tobacco Use Disorder.

What interventions are being tested in trial NCT01497158?

The interventions under investigation include: Self-help brochure (OTHER), Biomarker feedback (OTHER).

Who is sponsoring clinical trial NCT01497158?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01497158 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.